TY  - BOOK
AU  - Barnett, Christopher F
TI  - Pulmonary Arterial Hypertension: Diagnosis and Treatment. [Review]
SN  - 0733-8651
PY  - 2016///
KW  - *Antihypertensive Agents/tu [Therapeutic Use]
KW  - *Diagnostic Imaging/mt [Methods]
KW  - *Heart Ventricles/dg [Diagnostic Imaging]
KW  - *Hypertension, Pulmonary/di [Diagnosis]
KW  - Cardiac Catheterization
KW  - Echocardiography
KW  - Electrocardiography
KW  - Heart Ventricles/pp [Physiopathology]
KW  - Humans
KW  - Hypertension, Pulmonary/pp [Physiopathology]
KW  - Hypertension, Pulmonary/th [Therapy]
KW  - Magnetic Resonance Imaging, Cine
KW  - Radiography, Thoracic
KW  - MedStar Heart & Vascular InstituteIN  - Barnett, Christopher F. Medstar Heart and Vascular Institute, 110 Irving Street Northwest Washington, DC 20010, USA; Critical Care Medicine Department, National Institutes of Health, 10 Center Drive, Room 2C145, Bethesda, MD 20892, USA.IN  - Alvarez, Paulino. Department of Cardiology, Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, 6550 Fannin Street, Smith Tower, Suite 1901, Houston, TX 77030, USA.IN  - Park, Myung H. Division of Heart Failure and Transplant, Department of Cardiology, Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, 6550 Fannin Street, Smith Tower, Suite 1901, Houston, TX 77030, USA. Electronic address: mhpark@houstonmethodist.org
KW  - Journal Article
KW  - Review
N1  - Available online from MWHC library: 1996 - present, Available in print through MWHC library: August 1998 - February 2004
N2  - Copyright © 2016 Elsevier Inc. All rights reserved; Pulmonary arterial hypertension (PAH) is a specific, rare disease characterized by a well-described pattern of pulmonary vascular remodeling. The elevated pulmonary artery pressure in PAH results in increased right ventricular afterload, which, if untreated, leads rapidly to right ventricular failure and death. Recent marked expansion in knowledge about PAH has resulted in the development of effective therapies that improve quality of life and survival. However, delays in diagnosis and suboptimal treatment remain significant barriers to achieving optimal patient outcomes. Continued success in raising PAH awareness, earlier diagnosis, and the availability of new therapies mean a promising future for PAH patients.
UR  - https://dx.doi.org/10.1016/j.ccl.2016.04.006
ER  -